SRTS on Nasdaq

Sensus Healthcare, Inc.

American surgical and medical instruments and apparatus company. Summary from the record

Price unavailable

Last updated Oct 19, 2026.

Overview

Compare with MELA Sciences, Premier Air Charter Holdings Inc. or Orchestra BioMed Holdings, Inc., or pick any stock.

  • TickerSRTS on Nasdaq2
  • IndustrySurgical & Medical Instruments & Apparatus2
  • HeadquartersBoca Raton, United States2
  • Incorporated inDE3
  • Business address851 Broken Sound Parkway Nw, Suite 215, Boca Raton, Fl 334873
  • Filer categoryNon-accelerated filer, Smaller reporting company3
  • Legal formCorporation2
  • LEI549300F3JF8NCDJJZW042
  • StatusActive2
  • LEI statusLapsed (not renewed)2
  • Registered addressC/O CORPORATE CREATIONS NETWORK INC., 19803 Wilmington, United States2
  • Registered withDivision of Corporations, Department of State, 48207692

See how the biggest companies compare on our leaderboards

As of December 31, 2025, the Company had installed 955 units in 21 countries, primarily in the United States.4 From its latest annual report

Financials

From the company’s reports to the SEC. Every number links to the filing it came from.

Key numbers, fiscal 2025

43.2%Gross margin5
-37.5%Operating margin5
-28.1%Net margin5
-34.3%Revenue growth, 20255
-16.0%Return on equity5
$332.0KFree cash flow5

What sells

Revenue by product, business segment and region, as the company reports it to the SEC.

Products and services

Product brought in 72% of the revenue Sensus Healthcare, Inc. broke down this way in fiscal 2025.

  1. Product$19.8M572%down 46% from 2024
  2. Service Revenue$3.5M513%up 8% from 2024
  3. Service$2.5M59%up 30% from 2024
  4. Product Revenue$1.7M56%up 597% from 2024
Products and services by year
Products and services20242025
Product$36.4M$19.8M
Service Revenue$3.2M$3.5M
Service$2.0M$2.5M
Product Revenue$247.0K$1.7M

Regions

United States brought in 92% of the revenue Sensus Healthcare, Inc. broke down this way in fiscal 2025.

  1. United States$25.4M592%down 37% from 2024
  2. [Canada]$2.0M57%up 40% from 2024
  3. Other$90.0K50%down 51% from 2024
Regions by year
Regions20242025
United States$40.2M$25.4M
[Canada]$1.4M$2.0M
Other$182.0K$90.0K

Where the money goes

Where each dollar of revenue went, fiscal 2025

  • Cost of revenue47¢$15.6M
  • Research and development23¢$7.8M
  • Selling, general and admin24¢$7.9M
  • Income tax6¢$1.9M

Out of $27.5M in revenue.5 The company lost money this year.

Where each dollar of operating cash went, fiscal 2025

  • Capital spending37¢$196.0K
  • Share buybacks57¢$300.0K
  • Kept or used elsewhere6¢$32.0K

Out of $528.0K of cash from operations.5

Financial statements

Revenue6789105$27.5M in 2025+1% since 2019
0$20.0M$40.0M$60.0M2019: $27.3M$27.3M20192020: $9.6M$9.6M2020−65%2021: $27.0M$27.0M2021+182%2022: $44.5M$44.5M2022+65%2023: $24.4M$24.4M2023−45%2024: $41.8M$41.8M2024+71%2025: $27.5M$27.5M2025−34%
Gross profit6789105$11.9M in 2025−32% since 2019
0$10.0M$20.0M$30.0M2019: $17.6M$17.6M20192020: $5.2M$5.2M2020−70%2021: $17.0M$17.0M2021+224%2022: $29.6M$29.6M2022+74%2023: $14.1M$14.1M2023−53%2024: $24.4M$24.4M2024+74%2025: $11.9M$11.9M2025−51%
Operating income6789105-$10.3M in 2025+424% since 2019
-$20.0M-$10.0M0$10.0M$20.0M2019: -$2.0M-$2.0M20192020: -$8.2M-$8.2M2020+318%2021: $4.1M$4.1M20212022: $14.8M$14.8M2022+260%2023: -$382.0K-$382.0K20232024: $8.1M$8.1M20242025: -$10.3M-$10.3M2025
Net income6789105-$7.7M in 2025+354% since 2019
-$10.0M0$10.0M$20.0M$30.0M2019: -$1.7M-$1.7M20192020: -$6.8M-$6.8M2020+302%2021: $4.1M$4.1M20212022: $24.2M$24.2M2022+489%2023: $485.0K$485.0K2023−98%2024: $6.6M$6.6M2024+1271%2025: -$7.7M-$7.7M2025

Every line of the income statement as filed: the last 2 fiscal years, latest first.5

Period ending2025-12-312024-12-31
Revenues$27.5M$41.8M
Cost of sales$15.6M$17.4M
Gross profit$11.9M$24.4M
General and administrative$7.9M$7.1M
Selling and marketing$6.5M$5.0M
Research and development$7.8M$4.2M
Total operating expenses$22.2M$16.3M
(Loss) income from operations-$10.3M$8.1M
Interest income, net$683.0K$932.0K
Other income, net$683.0K$932.0K
(Loss) income before income taxes-$9.6M$9.0M
(Benefit from) provision for income taxes-$1.9M$2.4M
Net (loss) income-$7.7M$6.6M
Net (loss) income per share - basic-$0.47$0.41
Net (loss) income per share - diluted-$0.47$0.41
Weighted average number of shares used in computing net (loss) income per share - basic16.3M shares16.3M shares
Weighted average number of shares used in computing net (loss) income per share - diluted16.3M shares16.4M shares

Compare Sensus Healthcare, Inc. with another company

Leadership

Who has led Sensus Healthcare, Inc., and when. Pick a name to see everywhere that person has worked.

Chief executive

  1. Joseph C. Sardano2016–now

President

  1. Michael Sardano2022–now

Chief financial officer

  1. Javier Rampolla2020–now

Chief operating officer

  1. Nicolas Soro2020–2022
  2. Magdalena Martinez2023–now
20202025
Board members and other officers (17)

Former names

  • Sensus Healthcare, LLCJul 2, 2010 to Dec 30, 20153

Timeline

  1. Jun 2, 2016New chief executive Joseph C. Sardano becomes CEO13
  2. May 7, 2010Founded Sensus Healthcare, Inc. is founded2

Filings

150 filings to the SEC since October 2021: 5 annual reports, 15 quarterly reports, 42 major events, 71 insider forms, 5 large holders, 12 other. The latest 20:

  1. Aug 31, 20264 EDGAR
  2. Aug 28, 20264 EDGAR
  3. Aug 25, 20264 EDGAR
  4. Aug 24, 20264 EDGAR
  5. Aug 24, 20264 EDGAR
  6. Aug 14, 202610-Q EDGAR
  7. Aug 13, 20268-K EDGAR
  8. Jun 5, 20268-K EDGAR
  9. Jun 2, 20268-K EDGAR
  10. May 18, 2026SD EDGAR
  11. May 13, 202610-Q EDGAR
  12. May 12, 20264 EDGAR
  13. May 7, 20268-K EDGAR
  14. Apr 29, 2026DEF 14A EDGAR
  15. Apr 23, 20264/A EDGAR
  16. Apr 22, 20263/A EDGAR
  17. Apr 22, 20264/A EDGAR
  18. Apr 22, 20264/A EDGAR
  19. Mar 4, 202610-K EDGAR
  20. Feb 26, 20264 EDGAR

The 150 filings since October 2021 can be filtered by form type and year here when JavaScript is on.

Every filing from the last five years, summarized. The full record is on SEC EDGAR.

Insider trades

65 open-market trades by officers, directors and large owners since October 2021: 30 buys and 35 sales. Grants, option exercises and gifts are left out.

DateWhoTradeSharesPriceValueFiling
Aug 31, 2026Sachetta EricDirectorBuy27,304$3.54$96.7KForm 4
Aug 28, 2026Sachetta EricDirectorBuy37,537$3.44$129.1KForm 4
Aug 27, 2026Sachetta EricDirectorBuy10,925$3.18$34.7KForm 4
Aug 26, 2026Sachetta EricDirectorBuy9,708$3.29$31.9KForm 4
Aug 24, 2026Sachetta EricDirectorBuy34,697$3.25$112.8KForm 4
Aug 21, 2026Sachetta EricDirectorBuy7,000$3.25$22.8KForm 4
Aug 20, 2026Sachetta EricDirectorBuy24,000$3.13$75.1KForm 4
Aug 20, 2026Sardano Joseph CCHIEF EXECUTIVE OFFICERBuy20,000$3.02$60.4KForm 4
May 12, 2026Sachetta EricDirectorBuy1,500$3.34$5.0KForm 4
Feb 24, 2026Sachetta EricDirectorBuy2,000$3.81$7.6KForm 4
Nov 21, 2025Sachetta EricDirectorBuy7,000$3.93$27.5KForm 4
Nov 18, 2025Sardano MichaelPRESIDENT AND GENERAL COUNSELBuy1,000$3.80$3.8KForm 4
Nov 18, 2025Sardano Joseph CCHIEF EXECUTIVE OFFICERBuy25,000$4.03$100.8KForm 4
Nov 13, 2025Sachetta EricDirectorBuy2,500$4.50$11.2KForm 4
Nov 11, 2025Sardano MichaelPRESIDENT AND GENERAL COUNSELBuy2,000$4.27$8.5KForm 4
Nov 11, 2025Sardano MichaelPRESIDENT AND GENERAL COUNSELBuy2,000$4.26$8.5KForm 4
Nov 11, 2025Sardano MichaelPRESIDENT AND GENERAL COUNSELBuy1,000$4.26$4.3KForm 4
Aug 13, 2025Sardano MichaelPRESIDENT AND GENERAL COUNSELBuy1,000$3.37$3.4KForm 4
Feb 10, 2025Rampolla JavierCHIEF FINANCIAL OFFICERBuy501$5.95$3.0KForm 4
Feb 10, 2025Sardano MichaelPRESIDENT AND GENERAL COUNSELBuy1,000$5.95$6.0KForm 4

All 65 trades can be filtered by person here when JavaScript is on.

From Forms 4 filed with the SEC.

Major holders

Investors who own more than 5% of the shares must tell the SEC: a 13D if they may seek to influence the company, a 13G if they hold passively.

  • Joseph C. SardanoSCHEDULE 13G/A, 1 filing May 22, 202534
  • Edwin Lee SolotSCHEDULE 13G/A, 4 filings Feb 7, 2022 to Feb 7, 202535

Held by these funds

The largest holders among investment managers' 13F reports for the quarter ending Jun 30, 2026, the top 25 of 38. Change is in shares since the quarter before.

FundSharesValueShare of the fundChange
Pacific Ridge Capital Partners, LLC789,675$2.4M0.4%−6,397
Vanguard Capital Management LLC660,402$2.0M0.0%+12,177
Dimensional Fund Advisors LP316,121$954.8K0.0%−71,271
Divisadero Street Capital Management, LP278,485$841.0K0.0%−7,593
Renaissance Technologies LLC242,334$731.8K0.0%−9,900
Geode Capital Management, LLC154,152$465.7K0.0%−11,398
UBS Group AG152,573$460.8K0.0%−20,297
Sachetta, LLC152,008$459.1K0.2%+1,500
Greenline Wealth Management LLC128,774$388.9K0.3%No change
North Star Investment Management Corp.125,586$379.3K0.0%No change
Bank of New York Mellon Corp100,410$303.2K0.0%No change
BlackRock, Inc.83,555$252.3K0.0%+12,388
Vanguard Fiduciary Trust Co76,289$230.4K0.0%+559
State Street Corp69,252$209.1K0.0%No change
Mindset Wealth Management, LLC52,100$157.3K0.0%No change
Northern Trust Corp28,187$85.1K0.0%−40,006
Chapin Davis, Inc.26,000$78.5K0.0%No change
American Century Companies Inc21,272$64.2K0.0%No change
Ashton Thomas Private Wealth, LLC16,307$49.2K0.0%+639
EP Wealth Advisors, LLC16,065$48.5K0.0%New
StoneX Group Inc.13,378$47.9K0.0%New
Jane Street Group, LLC12,518$37.8K0.0%−9,834
XTX Topco Ltd12,178$36.8K0.0%New
Rockefeller Capital Management L.P.7,000$21.1K0.0%No change
Vanguard Global Advisers, LLC4,961$15.0K0.0%No change

13F reports cover disclosed long positions in U.S. stocks only.

Sources

The numbers on this page point here. Each one links to the record it came from.

  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6
  7. 7
  8. 8
  9. 9
  10. 10
  11. 11
  12. 12
  13. 13
  14. 14
  15. 15
  16. 16
  17. 17
  18. 18
  19. 19
  20. 20
  21. 21
  22. 22
  23. 23
  24. 24
  25. 25
  26. 26
  27. 27
  28. 28
  29. 29
  30. 30
  31. 31
  32. 32
  33. 33
  34. 34
  35. 35